Overexpression of miRNA-433-5p protects acute spinal cord injury through activating MAPK1

C-L Zhou1, F Li, X-W Wu

  • 1Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. zhouchanglin119@163.com.

Abstract

Insights

MicroRNA-433-5p (miRNA-433-5p) protects against spinal cord injury (SCI) by targeting MAPK1. Restoring miRNA-433-5p levels improves motor function and reduces inflammation after SCI.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Spinal cord injury (SCI) leads to significant motor dysfunction and pathological lesions.
  • The role of specific microRNAs in SCI pathogenesis remains incompletely understood.
  • Mitogen-activated protein kinase 1 (MAPK1) is implicated in inflammatory responses following injury.

Purpose of the Study:

  • To investigate the role of microRNA-433-5p (miRNA-433-5p) in acute spinal cord injury (SCI).
  • To determine if miRNA-433-5p influences pathological lesions by targeting mitogen-activated protein kinase 1 (MAPK1).

Main Methods:

  • Established a mouse model of SCI via hitting injury.
  • Quantified serum levels of miRNA-433-5p and MAPK1 in SCI patients and mice.
  • Assessed grip strength in SCI mice post-intervention.
  • Utilized Dual-Luciferase reporter gene assay to confirm miRNA-433-5p and MAPK1 interaction.
  • Detected iNOS protein levels via Western blot in response to miRNA-433-5p and MAPK1 manipulation.

Main Results:

  • Serum miRNA-433-5p was downregulated, while MAPK1 was upregulated in SCI patients and mice.
  • SCI mice exhibited significantly reduced grip strength, which was reversed by miRNA-433-5p overexpression.
  • MAPK1 was confirmed as a direct target of miRNA-433-5p, with its expression negatively regulated.
  • Overexpression of miRNA-433-5p reduced iNOS protein levels, indicating an anti-inflammatory effect.

Conclusions:

  • miRNA-433-5p plays a protective role in acute SCI.
  • Overexpression of miRNA-433-5p mitigates motor dysfunction and inflammatory responses post-SCI.
  • The therapeutic effect of miRNA-433-5p is mediated through its targeting of MAPK1.